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ABSTRACT
Chromatin immunoprecipitation (ChIP) is a powerful
technique for studying protein–DNA interactions.
Drawbacks of current ChIP assays however are a
requirement for large cell numbers, which limits
applicability of ChIP to rare cell samples, and/or
lengthy procedures with limited applications. There
are to date no protocols for fast and parallel ChIPs
of post-translationally modified histones from small
cell numbers or biopsies, and importantly, no proto-
col allowing for investigations of transcription factor
binding in small cell numbers. We report here the
development of a micro (k) ChIP assay suitable for
up to nine parallel quantitative ChIPs of modified
histones or RNA polymerase II from a single batch
of 1000 cells. kChIP can also be downscaled to
monitor the association of one protein with multiple
genomic sites in as few as 100 cells. kChIP is appli-
cable to small fresh tissue biopsies, and a cross-
link-while-thawing procedure makes the assay
suitable for frozen biopsies. Using kChIP, we char-
acterize transcriptionally permissive and repressive
histone H3 modifications on developmentally regu-
lated promoters in human embryonal carcinoma
cells and in osteosarcoma biopsies. kChIP creates
possibilities for multiple parallel and rapid transcrip-
tion factor binding and epigenetic analyses of rare
cell and tissue samples.
INTRODUCTION
Protein–DNA interactions are essential for genomic
stability, DNA replication and repair, chromosome
segregation, transcription and epigenetic silencing of
gene expression. Chromatin immunoprecipitation (ChIP)
is a powerful technique for studying interactions of DNA
with proteins including transcription factors (1–3) and
histones (4–6), whose post-translational modiﬁcations
regulate gene expression (7–9). A drawback of current
ChIP assays, however, is the requirement for large cell
numbers (in the 10
6–10
7 range), which limits applicability
of ChIP to rare cell samples such as small stem cell batches
or tissue biopsies. A carrier ChIP protocol (CChIP) for a
single histone immunoprecipitation from 100 cells under
native conditions has been published, however it remains
tedious and unsuitable for transcription factors (5).
A recent fast ChIP protocol circumvents two cumbersome
steps of a conventional ChIP assay (10,11), but it is
suitable for large cell samples. We recently reported a
quick and quantitative Q
2ChIP assay suitable for up to
1000 histone immunoprecipitations or 100 transcription
factor immunoprecipitations (including Oct4) from
100000 cells (12).
Application of ChIP to stem cell and embryo biology
requires a robust assay for immunoprecipitation of
histones or transcription factors from small (hundreds or
fewer) cell numbers. We report here a one-day micro (m)
ChIP assay suitable for up to nine parallel ChIPs of
modiﬁed histones and/or RNA polymerase II (RNAPII)
from a single batch of 1000 cells. The assay can be
downscaled for monitoring association of one protein with
multiple genomic sites in as few as 100 cells, and has been
adapted for fresh or frozen tissue samples. The assay was
validated by assessing several post-translational modiﬁca-
tions of histone H3 and the binding of RNAPII in human
embryonal carcinoma (EC) cells and in biopsies of human
osteosarcoma xenografts, on the promoters of the devel-
opmentally regulated OCT4 and NANOG genes (13,14),
the tissue-speciﬁc SLC10A6 gene (15) and the house-
keeping gene GAPDH.
MATERIALS AND METHODS
Materials
Undiﬀerentiated EC cells (NCCIT) were cultured as
described (12). The osteosarcoma xenograft was estab-
lished from a primary tumor of a male 7-year old. The
tumor was evaluated as a Grade 4 Osteoblastic/
Telangiectatic Osteosarcoma. Tumor tissue was grown
subcutaneously on a nude mouse. The tumor was
collected, washed in phosphate buﬀered saline (PBS) and
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3 pieces. The pieces were
processed fresh or frozen in liquid nitrogen and stored
at  808C. Antibodies against H3K9ac (cat# 06-942),
H3K9m2 (cat# 07-441), H3K9m3 (cat# 07-442) and
H3K27m3 (cat# 05-851) were from Upstate (www.
upstate.com). Anti-H3K9m3 antibodies used in biopsy
ChIPs were from Diagenode (cat# pAb-056-050;
www.diagenode.com). Antibodies to H3K4m2
(cat#Ab7766) and H3K4m3 (cat# Ab8580) were from
Abcam (www.abcam.com). Antibodies to RNAPII
were from Santa Cruz Biotechnology (cat# sc-899;
www.scbt.com). Chelex-100 was from BioRad (cat# 142-
1253; www.biorad.com). All other reagents were from
Sigma-Aldrich (www.sigma-aldrich.com) unless otherwise
stated.
kChIP assay
The basis of the mChIP assay was the Q
2ChIP assay (12),
with modiﬁcations. The LowCell# ChIP kit (Diagenode)
was applied for the Q
2ChIPs carried out here. Dynabeads
Protein A (10ml; Dynal Biotech; www.invitrogen.com)
were added to 90ml RIPA buﬀer (10mM Tris–HCl, pH
7.5, 1mM EDTA, 1% Triton X-100, 0.1% SDS, 0.1%
Na-deoxycholate, 100mM NaCl) and 2.4mg primary
antibody in a 0.2ml PCR tube and rotated at 40rpm for
2h at 48C. PCR tubes were in the form of 8-tube strips
handled in a magnetic rack (cat# kch-816-001; Diagenode)
chilled on ice.
Chromatin preparation. Cells were harvested by trypsini-
zation in presence of 20mM butyrate and 1000 or 10000
cells (depending on starting number; see Results) were re-
suspended in 500ml PBS/butyrate. The method described
here is also applicable to cell numbers between 10000
and 50000.
We carried out an all-in-one tube preparation of
chromatin in order to minimize exposure to plastic
surfaces and sample handling, and reduce loss of material.
Proteins and DNA were cross-linked with 1% formalde-
hyde for 8min at room temperature and cross-linking was
stopped with 125mM glycine for 5min. Cells were
centrifuged at 470g in a swing-out rotor with soft
deceleration settings for 10min at 48C and washed twice
in 0.5ml ice-cold PBS/butyrate by gentle vortexing and
centrifugation as above. Ten to twenty microliter of buﬀer
was left with the pellet after removal of the last wash. Cells
were lysed by addition of 115ml room temperature lysis
buﬀer [50mM Tris–HCl, pH 8, 10mM EDTA, 1% SDS,
protease inhibitor cocktail (cat# P8340, Sigma-Aldrich),
1mM PMSF, 20mM butyrate] and subsequent vortexing.
Cells were incubated on ice for 5min, re-suspended by
vortexing and sonicated for 3 30s on ice with 30s
pauses, using a probe sonicator (Labsonic-M, 3-mm
probe; cycle 0.5, 30% power; Sartorius AG; www.sartor-
ius.com). This produced chromatin fragments of  500bp.
Alternatively, cells can be sonicated with a Bioruptor
(Diagenode) (data not shown). The sonicated lysate was
diluted 8-fold in RIPA buﬀer containing a protease
inhibitor cocktail, 1mM PMSF, 20mM butyrate (RIPA
ChIP buﬀer) to reduce SDS concentration to  0.1%.
To this end, 480ml RIPA ChIP buﬀer was mixed by
vortexing with  120ml lysate, the sample centrifuged at
12000g for 10min at 48C and the supernatant (chro-
matin) transferred to a chilled clean 1.5ml tube. Care was
taken to avoid aspiration of the sedimented material, thus
 50ml of the supernatant was left in the tube. RIPA ChIP
buﬀer (330ml) was added to the pellet (which is essentially
invisible), mixed by vortexing and the sample spun as
before. The supernatant was pooled with the ﬁrst super-
natant to yield a volume of chromatin suited for eight
ChIPs and one input reference.
When starting from 100 cells, cells were cross-linked
and washed as before and 20ml PBS/butyrate was left with
the washed pellet. Cells were lysed by mixing with 120ml
lysis buﬀer and a 3-min incubation, the nuclei were
centrifuged at 860g for 10min and the supernatant
discarded, leaving 20–30ml lysis buﬀer in the tube (Note
that leaving cells in lysis buﬀer for >3min before
centrifugation increases the chance of SDS precipitating.
If this occurs, the lysis buﬀer is removed after centrifuga-
tion, 200ml RIPA ChIP buﬀer are added, SDS is dissolved
by vortexing and nuclei are pelleted as described). RIPA
ChIP buﬀer (120ml) was added, the tube vortexed
thoroughly and cells sonicated as before but for 2 30s.
The resulting chromatin was pipetted several times with a
siliconized tip before transfer into a 0.2ml PCR tube
containing beads pre-incubated with antibodies (see
above) and from which the pre-incubation buﬀer (RIPA)
was previously removed. A chromatin sample identical to
that used in the ChIP was prepared to represent the input.
Immunoprecipitation and DNA recovery. Immunoprecipi-
tation and washes of the ChIP material were as described
(12). Chromatin was aliquoted into eight samples in 0.2ml
tubes containing antibody-bead complexes held to the wall
by a magnet, and from which the pre-incubation buﬀer
(RIPA) was removed, and one input sample (in a 1.5ml
tube for phenol-chloroform isoamylalcohol isolation, or
0.6ml tube for Chelex-100-mediated DNA isolation; see
subsequently). Beads were released into the suspension
and rotated at 40rpm for 2h at 48C. The ChIP material
was washed three times by 4-min incubations in 100mlo f
RIPA buﬀer and once in 100ml of 10mM Tris–HCl, pH
8.0, 10mM EDTA (TE) buﬀer, and transferred into a new
tube while in TE. DNA elution (1% SDS), cross-link
reversal and proteinase K digestion (50mg/ml) were
carried out in a single step for 2h at 688Co na
Thermomixer (Eppendorf; www.eppendorf.de). DNA
was extracted with phenol-chloroform isoamylalcohol,
ethanol-precipitated in presence of 10ml acrylamide carrier
(cat# A9099, Sigma-Aldrich) and dissolved in 100–300ml
TE (1000–100000-cell ChIP) or 30–50ml TE (100-cell
ChIP). For ChIPs starting with 100 cells, DNA was
puriﬁed using Chelex-100 (see subsequently).
Purification of ChIP DNA using Chelex-100. Chelex-100
mediated DNA puriﬁcation was as described (10) with
modiﬁcations for small samples and to speed up handling.
Speciﬁcally, after transferring the washed ChIP material
into a clean tube, the complex was centrifuged, TE was
removed and 40ml of 10% (wt/vol) Chelex-100 was added
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10min in a PCR machine and cooled to room temperature
before proteinase K (1ml at 20mg/ml) was added. Samples
were vortexed, incubated at 558C for 30min at 1300rpm
on a Thermomixer, boiled for 10min and quick-spun for
10s. Tubes were then allowed to stand still for  1min
without a magnet to allow beads to settle. With a
siliconized tip, 30ml of the supernatant were transferred
to a clean tube on ice. Ten microliter of MilliQ H2O were
added to the remaining beads, the sample was vortexed
and quick-spun for  3s using a minifuge. After the beads
settled, as much as possible of the supernatant (12–15ml)
was collected (volume must be consistent between tubes
when ChIP samples are to be compared) and pooled with
the ﬁrst supernatant. The DNA sample was used for PCR
or stored at  208C. Input DNA from 100 cells was
prepared using Chelex-100 as described earlier (10) except
that 40ml Chelex-100 beads were used and 10ml acryla-
mide carrier was included in the ethanol precipitation.
Puriﬁcation of ChIP DNA with Chelex-100 can be applied
to larger cell numbers (10) without aﬀecting the ChIP
PCR results compared to phenol-chloroform isoamyalco-
hol extraction (see Results).
Regardless of ChIP DNA isolation method, real-time
PCR data were expressed as percent ( SD) precipitated
(antibody-bound) DNA relative to input DNA, in two to
nine independent replicate ChIPs.
kChIP from biopsies
Fresh and frozen osteosarcoma biopsies ( 1mm
3) were
processed in a similar manner except that frozen biopsies
were frozen without cross-linking and thawed in freshly
prepared PBS containing 1% formaldehyde, 20mM
butyrate and protease inhibitors. Biopsies in PBS/
formaldehyde/butyrate without (fresh biopsies) or with
(frozen-thawed biopsies) protease inhibitors were vortexed
and incubated for 10min at room temperature. Fixation
was terminated with 125mM glycine for 5min, the sample
washed, and lysed by thorough resuspension by pipetting
in 120ml lysis buﬀer. The sample was incubated on ice
and sonicated for 30s. The lysate was centrifuged at
12000g for 10min at 48C and the supernatant transferred
into a chilled 0.6ml tube, leaving  30ml of buﬀer with
the pellet. This sedimentation step ensured removal
of remaining tissue aggregates. Another 30ml of lysis
buﬀer was added and the tube vortexed. After centrifuga-
tion as before,  50ml of the supernatant was pooled
with the ﬁrst supernatant and sonicated for another
2 30s on ice. The sonicated chromatin sample was
further processed for ChIP as described before (see
Chromatin preparation and Immunoprecipitation and
DNA recovery).
Polymerase chain reaction (PCR)
Immunoprecipitated DNA from 3–4 independent ChIPs
was analyzed by duplicate quantitative (q)PCR as
described (12). Reverse transcription (RT)–PCRs were
performed from 500ng total RNA using the Iscript cDNA
synthesis kit (BioRad) and 30 cycles of 958C3 0 s ,6 0 8C
30s and 728C3 0 s .GAPDH, OCT4 and NANOG ChIP
and RT–PCR primers were as described (12). SLC10A6
ChIP primers were 50-TGGCTTTGGCTTTGTTGTTT-30
and 50-AGGCTTTCCACTTCTGTTCTT-30 (228bp
amplicon) and RT–PCR primers were 50-GGGTCC
TCCTTCTGGTGGT-30 and 50-GCCAAGACTGGTG
GGTAAAA-30 (153bp amplicon).
RESULTS
Setup and validation ofkChIP
To test and validate the mChIP assay, we monitored the
association of H3K9ac (a modiﬁcation indicative of
transcriptional activity), H3K4m2 and H3K4m3 [modiﬁ-
cations associated with promoters but not necessarily
indicative or predictive of transcriptional activity (16,17)]
and of H3K9m2, H3K9m3 and H3K27m3 (three
transcriptionally repressive marks) with the GAPDH,
OCT4 and NANOG promoters in NCCIT cells
(Figure 1A). RT–PCR analysis shows that GAPDH,
OCT4 and NANOG were expressed (Figure 1B). Starting
material was for each ChIP, either chromatin from
100000 cells, chromatin from  1000 cells prepared
from a starting 10000 cells and divided into nine
samples (‘1000-cell ChIP’), or chromatin from  100 cells
prepared from 1000 cells and divided into nine samples
(‘100-cell ChIP’). Among the nine samples, eight were
dedicated to ChIP and one served as input chromatin
reference.
Quantitative PCR analysis of the ChIP DNA shows
that with chromatin from 100000 cells, H3K9ac, H3K4m2
and H3K4m3 were enriched on all promoters, whereas
repressive histone marks were at background level
(Figure 1C). This was in agreement with activation of
the genes in NCCIT cells (Figure 1B) and with previously
published Q
2ChIP data (12). Remarkably, the 1000-cell
ChIP (Figure 1D) and the 100-cell ChIP assays
(Figure 1E) produced a similar histone enrichment proﬁle
as with 100000 cells, indicating that scaling down by 1000-
fold maintained speciﬁcity of the assay.
We consistently noted however, enhanced precipitation,
relative to input, from small chromatin samples (compare
y-axis scales in Figure 1C–E). This is suggested to be due
to an increased antibody/bead-to-antigen ratio. Indeed,
we showed that reducing antibody concentration to 40%
relative to a standard Q
2ChIP condition reduced the PCR
signal by  50% while a 4-fold increase in antibody
concentration enhanced the PCR signal by >30%
(Supplementary Data, Figure 1). Nevertheless, while the
ratio of antibody-to-chromatin increases 1000-fold
between the 100000-cell and the 100-cell ChIP assay, the
ChIP eﬃciency (precipitation relative to input) increased
by 1.5–2-fold. This indicates that the relationship between
antibody concentration and ChIP eﬃciency is non-linear
in the range examined and that with low amounts of
chromatin, the antibody concentration is not limiting. The
relative background signal also increased when scaling
down ChIP (Figure 1D and E); however this did not aﬀect
the overall interpretation of the results (see Discussion).
These results indicate therefore that mChIP maintains
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scale assays.
kChIP issuitable for detection ofRNAPII binding to
genomicsites
We also examined whether mChIP was applicable to
assess transcription factor (RNAPII) binding to DNA.
Engagement of RNAPII to target promoters has been
used as an indicator of transcriptional activity or potential
for activity in genome-wide epigenetic studies (3,18).
RNAPII ChIPs were carried out in parallel to histone
ChIPs presented before, from the same chromatin
preparations (Figure 1F–H). RNAPII association with
GAPDH and OCT4 promoters was clearly detected under
each condition. As negative control for RNAPII binding,
we monitored RNAPII association with the inactive
SLC10A6 promoter (Figure 1B). Binding was dramati-
cally weaker than with GAPDH and OCT4 and con-
sistently near background levels (Figure 1F–H). We
concluded that mChIP is suited for analysis of histone
and RNAPII binding to genomic loci in parallel
immunoprecipitations from chromatin from as few as
100 cells. Starting with chromatin from 10 cells did
Figure 1. Development and validation of mChIP. (A) Genomic regions examined. Bars and numbers indicate the position of ChIP amplicons relative
to the transcription start site (TSS). PE, PP and CR1 delineate the proximal enhancer, proximal promoter and conserved region 1 of OCT4,
respectively. (B) RT-PCR analysis of expression of GAPDH, OCT4, NANOG and SLC10A6 in NCCIT cells. Plus (+) and minus ( ) indicate the
presence or absence of reverse transcriptase (RT). (C–E) ChIP analysis of H3 modiﬁcations (x-axis) in NCCIT cells on promoters of indicated genes.
(C) Analysis from chromatin of 100000 cells, (D) 1000 cells and (E) 100 cells. (F–H) ChIP analysis of RNAPII binding to GAPDH, OCT4 and
SLC10A6 promoters in the same chromatin samples as those examined for histones in (C–E). In (C–H), data are expressed as percent precipitation
relative to input chromatin (mean SD; 2–9 independent experiments).
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that the current reliable limit of mChIP for assessing
RNAPII binding to promoters is chromatin from
100 cells.
kChIP is applicable to100 cells as starting material
To determine whether mChIP was applicable to immuno-
precipitation of histones and non-histone proteins from
even smaller cell samples, chromatin was prepared from
separate batches of 100 NCCIT cells. DNA was isolated
from the ChIP material using Chelex-100 in order to
minimize sample handling when very little material is
present. We have shown that using Chelex-100 or phenol-
chloroform isoamylalcohol to purify ChIP DNA does not
aﬀect ChIP results (Supplementary Data, Figure 2).
Chelex-100-mediated DNA isolation also enhances DNA
recovery (data not shown). Figure 2A shows that proﬁles
of H3K9ac, H3K4m2 and H3K9m2 association with
GAPDH, OCT4 and NANOG promoters in these samples
were remarkably similar to those produced from those of a
split chromatin sample from 1000 cells (compare with
Figure 1E). In addition, mChIP enabled the detection of
H3K9m2 enrichment on the SLC10A6 promoter, in
agreement with its inactive state in NCCIT cells
(Figure 2A). Moreover, RNAPII was successfully immu-
noprecipitated from 100-cell samples and found to be
enriched on the GAPDH, OCT4 and NANOG promoters,
but not on the silent SLC10A6 promoter (Figure 2B).
Therefore, mChIP is compatible with immunoprecipitation
of histones and RNAPII from as few as 100 cells as
starting material.
Analysisof histonemodifications and RNAPIIbinding
inbiopsies
Increasing evidence for a role of epigenetics in aging and
in the development of cancer (19) reinforces the need for a
method allowing detailed epigenetic and transcription
factor binding studies in small tissue samples (20). Many
tumor samples exist today in the form of stored frozen
biopsies, not shown to date to be suited for ChIP analysis.
Only limited ChIP studies have to date been reported
using human lung, liver or post-mortem brain tissue
(21–23), presumably due to the lack of an eﬃcient ChIP
protocol. In these and in mouse studies (24,25), tissue
samples were relatively large, from >125mm
3 to processed
large organ samples or organ slices.
We determined whether mChIP was applicable to small
tissue samples. We examined fresh and deep-frozen
( 808C)  1mm
3 biopsies (duplicates of each) from a
human osteosarcoma xenograft. Chromatin from fresh
biopsies was prepared as described under Materials and
Methods. For frozen biopsies, a cross-link-while-thawing
step in presence of 20mM butyrate and protease inhibitors
was introduced to preserve histone acetylation and
intermolecular interactions in the dead tissue while
thawing. The rest of the procedure was as for fresh
samples. From each sample, six histone ChIPs, one
RNAPII ChIP and one negative control ChIP were
performed in parallel. PCR signal intensity from input
chromatin for each gene examined indicated that total
chromatin recovered from each biopsy was from  3000
cells (data not shown). Figure 3A shows histone H3
modiﬁcations and RNAPII binding patterns on the
GAPDH, NANOG, OCT4 and SLC10A6 promoters, in
relation to gene expression assessed by RT–PCR
(Figure 3B). Identical results were obtained from fresh
and frozen-thawed samples. Speciﬁcally, the active
GAPDH promoter was clearly enriched in H3K9ac,
H3K4m2 and K3K4m3, while none of the repressive
marks was detected (Figure 3A). Consistent with these
data, RNAPII also occupied the GAPDH promoter. The
embryonic genes OCT4 and NANOG were not expressed
in osteosarcomas and accordingly, promoters were
enriched in H3K9m2, H3K9m3 and in particular
H3K27m3. RNAPII was detected only at background
levels on these promoters, corroborating their inactive
state. The SLC10A6 promoter, also inactive in the
osteosarcoma samples, did not show signiﬁcant H3K9ac
but was enriched in H3K9m2 and to a lesser extent
H3K9m3 and H3K27m3 (Figure 3). All loci examined
were enriched in di- and trimethylated H3K4 regardless of
transcriptional status, in agreement with claims that
H3K4m3 marks promoters regardless of activity (16,17).
Altogether, these results indicate that seven diﬀerent
modiﬁed histones and RNAPII can be immunoprecipi-
tated, along with a negative control ChIP, from  1mm
3
tissue samples, either fresh or stored frozen. The results
Figure 2. mChIP is suitable for analysis of histone or RNAPII binding
in as few as 100 cells. (A) ChIP analysis of H3K9ac, H3K4m3 and
H3K9m3 in separate 100-cell samples for each antibody, and for a
no-antibody (No Ab) control. (B) ChIP analysis of RNAPII association
with the GAPDH, NANOG, OCT4 and SLC10A6 promoters 100-cell
samples. Two to four ChIPs were performed with each antibody. Data
are expressed as in Figure 1.
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compatible with transcription status. Under these condi-
tions, the amount of DNA recovered from ChIP on
biopsies is suﬃcient for examination of at least 20 genomic
sites in duplicate qPCRs. Note that alternatively,
chromatin prepared from tissue samples can be diluted
further to enable more ChIPs, with however, fewer PCRs
per ChIP.
DISCUSSION
We report here a mChIP assay suitable for up to nine
parallel ChIPs from a single 1000-cell sample. Up to
50mChIPs can be performed in 1day. The assay is
applicable to fresh or frozen tissue samples and is suitable
for immunoprecipitation of both modiﬁed histones and of
a transcription factor such as RNAPII. mChIP also
enables the analysis of as few as 100 cells without a need
for carrier chromatin as reported previously in the CChIP
assay (5). Under these conditions, only one immunopre-
cipitation is possible per chromatin sample, as in CChIP.
However, unlike CChIP, formaldehyde cross-linking
makes mChIP suitable for the analysis of both histone
and non-histone proteins. Although cross-linking is
not required for immunoprecipitating histones (4,5),
it makes the protocol more versatile than native ChIP
and, as shown here, is compatible with eﬃcient
immunoprecipitation.
The speciﬁcity of larger scale ChIP assays is maintained
with mChIP, as shown by the conservation of histone
enrichment proﬁles on the promoters examined as the
amount of input chromatin is decreased. Notably, mChIP
precipitates more material (determined as a percentage of
input) than standard ChIP, as illustrated by higher ChIP
eﬃciency. A potential limitation, however, is that mChIP
also results in enhanced background. This can be explained
by the reduction in the amount of input chromatin while
the total antibody-coupled bead surface area (the most
likely source of unspeciﬁc chromatin binding) in the assay
remains constant. An implication of increased background
in low cell number ChIP is that the ratio of signals,
e.g. H3K9ac over H3K9m2 decreases by  5-fold relative
to 100000-cell ChIP when the data are presented includ-
ing background (compare, e.g. Figure 1C with E).
Nevertheless, all modiﬁed histone binding proﬁles on the
loci examined are maintained under each condition: H3K9
acetylated promoters remain clearly marked as acetylated,
with no (or background) levels of H3K9 and H3K27
methylation. These arguments also hold true for RNAPII
binding patterns on the various promoters examined
(Figure F–H). It is likely that reducing cell numbers in
ChIP assays systematically results in enhanced background
[see also (12)], an issue simply dealt with recently in a
miniChIP assay by subtracting background values (26).
Clearly, a background subtraction in Figures 1 and 2 in the
present article would produce histone enrichment proﬁles
identical to those of 100000-cell ChIP assays; however,
Figure 3. mChIP analysis of the association of modiﬁed histones and RNAPII to GAPDH, OCT4, NANOG and SLC10A6 promoters in human
osteosarcoma biopsies. (A) ChIP analysis of fresh and frozen/thawed tissue samples (data from duplicate ChIPs from each sample). (B) RT-PCR
analysis of expression of the respective genes (30 PCR cycles). Plus (+) and minus ( ) indicate the presence or absence of reverse transcriptase (RT).
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to emphasize awareness of the background issue.
Biological interpretation of the data remains unaﬀected.
Carrying out up to nine parallel ChIPs from a common
chromatin preparation from 1000 cells enhances the
consistency of the amount of input chromatin in each
sample, making comparisons between ChIPs more robust
than comparisons between single ChIPs from separate
(100-cell) samples. With chromatin from 100 cells, four
genomic sites can be examined in duplicate qPCRs
on non-ampliﬁed DNA, and with 1mm
3 biopsies over
20 sites can be analyzed in duplicate qPCRs. The use of
increasingly sensitive commercial DNA ampliﬁcation kits
should allow the analysis of more genomic sites and
possibly of the whole genome with microarrays or by
direct sequencing. This remains to be determined. One
should nevertheless note that the amplitude of standard
deviations from qPCR assays increases as cell numbers
decrease. This is likely because the amount of target
genomic sequence is closer to the detection limit by real-
time PCR, so minor variations in the number of DNA
template molecules for PCR translate into enhanced
variability. The number of template molecules per PCR
is so low that inaccessibility of one molecule in the ﬁrst
PCR cycle can aﬀect ﬁnal quantiﬁcation. Increased
apparent variation between replicates in 100-cell ChIP
assays, therefore, reﬂects technical artifacts more than
biological variation.
The demonstration of successful RNAPII immunopre-
cipitation with mChIP creates possibilities for examining
other DNA-bound proteins. For example, detection of
polycomb-group repressors on target genes, which corre-
lates with H3K27 trimethylation on developmentally
regulated genes in embryonic stem cells (3,27), should
be possible from small amounts of human embryonic
stem cells or even embryos. Additionally, the rapidity of
the assay [see also (10)] may conceivably promote its
implementation in routine epigenetic examinations of
human material. However, because real-time PCR signals
are weak, it remains to be determined how mChIP on 100
cells would perform in instances of precipitation of low
abundance proteins or transiently bound proteins. We
have previously shown that ChIP of the embryo-speciﬁc
transcription factor Oct4 from chromatin from as a few
as 1000 cells is possible (12), a number which at present
constitutes the lowest reliable limit for this factor (our
unpublished data).
The mChIP assay has been applied to small tumor
samples. A limited number of studies have reported ChIP
assays from human (21–23) or murine (23–25,28) tissue
samples; however, these were signiﬁcantly larger than the
1mm
3 samples used here. Furthermore, in these studies,
ChIP protocols were conventional long protocols and no
more than one histone modiﬁcation or DNA binding
protein was examined. mChIP allows parallel analysis of
several histone modiﬁcations and RNAPII binding in
single biopsies, and this from either fresh or frozen
samples. Because mChIP can be applied to scarce
biological material, it is anticipated to enable the long
awaited clinical relevance of epigenetic assessments using
precious cell or tissue samples (20).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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